High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study

References

• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 Aug;584(7821):430–436.
   PubMed Web of Science ®Google Scholar
• Peckham H, de Gruijter NM, Raine C, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020 Dec 9;11(1):6317.
   PubMed Web of Science ®Google Scholar
• Stanelle-Bertram S, Schaumburg B, Mounogou Kouassi N, et al. SARS-CoV-2 induced CYP19A1 expression in the lung correlates with increased aromatization of testosterone-to-estradiol in male golden hamsters. Research Square Preprint. 2020.
   Google Scholar
• Force* TADT. Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012;307(23):2526–2533.
   Web of Science ®Google Scholar
• Yeap BB, Alfonso H, Chubb SA, et al. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men. J Clin Endocrinol Metab. 2012 Nov;97(11):4030–4039.
   PubMed Web of Science ®Google Scholar
• Bhasin S, Pencina M, Jasuja GK, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011 Aug;96(8):2430–2439.
   PubMed Web of Science ®Google Scholar
• Gubbels Bupp MR, Jorgensen TN. Androgen-induced immunosuppression. Front Immunol. 2018;9:794.
   Web of Science ®Google Scholar
• Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018;9:2279.
   PubMed Web of Science ®Google Scholar
• Bereshchenko O, Bruscoli S, Riccardi C. Glucocorticoids, sex hormones, and immunity. Front Immunol. 2018;9:1332.
   PubMed Web of Science ®Google Scholar
• Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-gamma promoter. J Immunol. 1991 Jun 15;146(12):4362–4367.
   PubMed Web of Science ®Google Scholar
• Nakaya M, Tachibana H, Yamada K. Effect of estrogens on the interferon-gamma producing cell population of mouse splenocytes. Biosci Biotechnol Biochem. 2006 Jan;70(1):47–53.
   PubMed Web of Science ®Google Scholar
• Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004 Feb;75(2):163–189.
   PubMed Web of Science ®Google Scholar
• Dhindsa S, Zhang N, McPhaul MJ, et al. Association of circulating sex hormones with inflammation and disease severity in patients with COVID-19. JAMA Netw Open. 2021 May 3;4(5):e2111398.
   PubMed Web of Science ®Google Scholar
• Salonia A, Pontillo M, Capogrosso P, et al. Severely low testosterone in males with COVID-19: A case-control study. Andrology. 2021 Feb 26;9(4):1043–1052.
   Web of Science ®Google Scholar
• Carnegie C. Diagnosis of hypogonadism: clinical assessments and laboratory tests. Rev Urol. 2004;6(Suppl 6):S3–S8.
   PubMedGoogle Scholar
• Ross A, Bhasin S. Hypogonadism: Its prevalence and diagnosis. Urol Clin North Am. 2016 May;43(2):163–176.
   Web of Science ®Google Scholar
• Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol. 2011 Nov;165(5):687–701.
   PubMed Web of Science ®Google Scholar
• Morris PD, Channer KS. Testosterone and cardiovascular disease in men. Asian J Androl. 2012 May;14(3):428–435.
   PubMed Web of Science ®Google Scholar
• Malkin CJ, Pugh PJ, Morris PD, et al. Low serum testosterone and increased mortality in men with coronary heart disease. Heart. 2010 Nov;96(22):1821–1825.
   PubMed Web of Science ®Google Scholar
• Kelly DM, Jones TH. Testosterone: a metabolic hormone in health and disease. J Endocrinol. 2013 Jun;217(3):R25–R45.
   PubMed Web of Science ®Google Scholar
• Dhindsa S, Furlanetto R, Vora M, et al. Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes. Diabetes Care. 2011 Aug;34(8):1854–1859.
   PubMed Web of Science ®Google Scholar
• Kyrou I, Karteris E, Robbins T, et al. Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med. 2020 Jul 15;18(1):220.
   PubMed Web of Science ®Google Scholar
• Hu X, Chakravarty SD, Ivashkiv LB. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev. 2008 Dec;226:41–56.
   PubMed Web of Science ®Google Scholar
• Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020 Jun;20(6):355–362.
   PubMed Web of Science ®Google Scholar
• Rowland SP, O'Brien Bergin E. Screening for low testosterone is needed for early identification and treatment of men at high risk of mortality from Covid-19. Crit Care. 2020 Jun 19;24(1):367.
   PubMed Web of Science ®Google Scholar
• Younis JS, Skorecki K, Abassi Z. The double edge sword of testosterone’s role in the COVID-19 pandemic [Mini Review]. Front Endocrinol. 2021;2021-March-16;12(81).
   Google Scholar
• Giagulli VA, Guastamacchia E, Magrone T, et al. Worse progression of COVID-19 in men: Is testosterone a key factor? Andrology. 2021 Jan;9(1):53–64.
   PubMed Web of Science ®Google Scholar
• Mohamed MS, Moulin TC, Schioth HB. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. 2021 Jan;71(1):3–8.
   PubMed Web of Science ®Google Scholar
• Schroeder M, Schaumburg B, et al. Sex hormone and metabolic dysregulations are associated with critical illness in male Covid-19 patients 2020 Dec 20; preprint; https://www.medrxiv.org/content/https://doi.org/10.1101/2020.05.07.20073817v2
   Google Scholar